China has seen remarkable progress in diabetes research over the past two decades

September 29, 2018

In the period of 1995 to 2015, China has seen remarkable progress in diabetes research, according to a study recently published by SCIENCE CHINA Life Sciences.

During the past two decades when China has experienced unprecedented economic growth, non-communicable diseases, such as diabetes, have gained epidemic proportions as well, potentially owing to the combination of increased life expectancy and unhealthy lifestyles. The prevalence of diabetes has increased dramatically from 0.67% in 1980 to 2.51% in 1994 and to 10.9% in 2013; which has seen China rising to have the largest number of diabetes patients worldwide. This number continues to grow and puts ongoing strains on the medical resources. Therefore, there is an urgent need to stop the diabetes epidemic and slow down the progression to diabetic complications.

A research group led by Jianping Weng at The Third Affiliated Hospital of Sun Yat-sen University in Guangzhou reviewed all diabetes research studies conducted in China between 1995 and 2015, and scrutinized the publication number, publication influence, progress, and unmet demands of diabetes research in China.

According to the bibliometric analysis in the study, diabetes research in China has progressed remarkably over the past two decades. Consistent with the rapid growth in China's Gross Domestic Product (GDP), scientific research funds have all been surging during the same period. The increase in the investment in science has contributed to the tremendous growth in the number of diabetes publications (Figure 1). The progress can not only be identified in quantity, but in publication influence when analyzing by journal distribution, by citation number and by publications cited by the guidelines as well. The total citation number and citation number per publication of diabetes publications especially, has been on the rise in the past two decades; moreover, this trend is predicted to persist at least until 2020 (Figure 2 and 3).

The deep review of this study highlights important findings of clinical research, basic research and traditional Chinese medicine (TCM). A total of 3,524 papers are identified as clinical research papers, most of which are on type 2 diabetes mellitus (T2DM). These papers have clarified our understanding of the epidemiological pattern, time trends, and glycemic control rate in T2DM patients in China. Innovative studies, such as those on the prevention of T2DM with lifestyle interventions, those on the treatment of T2DM with short-term intensive insulin therapy and those exploring the potential future role of gut microbial markers and miRNAs in T2DM pathology and diagnosis, have established milestones in both diabetes research and clinical practice. Total 4,628 basic studies are identified, which outstrips the number for clinical research, indicating that more basic research studies in this field were conducted in China. Among basic research papers, 3/4 are related to pharmacology and therapeutics. Metabolism, genetics/genomes/proteomics/metabolomics, and complications are the three other areas of focus. Total 374 papers are associated with TCM?among which, 332 are related to herbal medicine while 15 are regarding acupuncture. More than 200 herbs or compound formulae (Fufang) were studied. Berberine, Astragali radix (Huang qi), and Lycium bararu (Gou qi) are the three most commonly studied herbs. The citation metrics of TCM are slightly superior to those of all papers in the field of diabetes, suggesting that TCM studies attract more attention than the average in the field of diabetes.

According to the authors, these advancements mentioned above, however, struggled to adequately manage the fast-rising diabetes epidemic in China. Furthermore, halting the rise of the diabetes epidemic and developing a cure for diabetes seem unlikely in the near future. Therefore, the authors addressed opportunities to strengthen researches, including new drug development, high quality studies on health economics, and healthcare quality improvement studies. The enhancement of applied clinical research, such as lifestyle interventions and complications prevention and treatment, conducted throughout the different stages of the disease (diabetes susceptibility, pre-diabetes, diabetes, and diabetic complication), is of great significance. As the era of artificial intelligence is approaching by leaps and bounds, a new perspective of thinking on diabetes is to be summoned for China when it comes to tackling such a huge number of patients, especially thus far there has been no sign for the tipping point of diabetes epidemic.

"Scientific advancements can invigorate the clinical practice, double the efficiency, and lead to the implementation of related policies that impact the entire country." said Professor Jianping Weng, the corresponding author of the study and past president of the Chinese Diabetes Society. "This study was conducted with the aim of gaining new insights regarding current scenario and future scope for researchers, healthcare providers in the field of diabetes, and the respective policy makers."
-end-
This research was funded by the National Key Research and Development Program of China grant and National Health and Family Planning Commission Foundation for Public Welfare Industry Research Project.

See the article:

Wu, Z., Jin, T., and Weng, J. (2018). A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci 61, https://doi.org/10.1007/s11427-018-9377-y

http://engine.scichina.com/publisher/scp/journal/SCLS/doi/10.1007/s11427-018-9377-y?slug=full%20text

Science China Press

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.